TrialCancer science2024

Concurrent nimotuzumab and intensity-modulated radiotherapy for elderly patients with locally advanced nasopharyngeal carcinoma.

Caineng Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.